With a background in Bioscience Engineering and a Master’s degree in Bioinformatics from Ghent University, Lore bridges biology and technology to create solutions that make a real impact in healthcare. Combining expertise in AI, bioinformatics, and software engineering, she develops technologies that advance personalized cancer immunotherapy.
As Chief Technology Officer at myNEO Therapeutics, Lore leads the development of cutting-edge algorithms at the intersection of biology and data science. She also spearheaded the discovery of camyoRNAs — a novel class of dark genome targets that open new avenues for next-generation immunotherapies.